Malgorzata Franczak, MD

Professor

view physician profile

Locations

Froedtert Hospital
Zablocki VA Medical Center
Neuroscience Institute – Specialty Clinics

Specialties

Neurology

Languages

Polish, English

Neurology-Appointment by Referral Only

(414) 955-6688

Education

MD - Doctor of Medicine

Biography

Specialty

Adult Neurology

Subspecialties

Neurogenerative Disorders
Dementia
Normal Pressure Hydrocephalus

Training

Internship, Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, 1994-1995

Resident, Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, 1995-1998

Fellowship, Dementia/EMG, Medical College of Wisconsin, Milwaukee, Wisconsin, 1998-1999

Societies

American Academy of Neurology
Member of Scientific Advisory Committee, Alzheimer's Association, Southeastern Wisconsin Chapter
Wisconsin Neurological Society (Board Member)

View Faculty Collaboration Database profile

Honors and Awards

Deans Merit Scholarship of Academic Achievements Honor Student, 1985
Deans Merit Scholarship of Academic Achievements Honor Student, 1986
Deans Merit Scholarship of Academic Achievements Honor Student, 1987

Research Interests

Dementia and Aging, Neurogenerative Disorders

Research Projects

Preclinical Diagnosis of Alzheimer Disease with Magnetic Resonance Spectroscopy (Principal Investigator)

Spin-Lock Magnetic Resonance Imaging of Muscle in Patients With Autosomal Recessive Limb Girdle Muscular Dystrophy.

Metrifonate Investigational Nation Wide Trial (M.I.N.T.) Protocol D97-019. (Subinvestigator)

A randomized, double-blind, placebo-controlled 12-month safety and efficacy trial of Idebenone (CV-2619) 240 mg TID and 360 TID in patients with probable Alzheimer's Disease. (Subinvestigator)

Gingko Biloba special extract Egb 761 in dementia of the Alzheimer's type. A double-blind multicenter study. (Subinvestigator)

Independent life in the elderly. (Co investigator)

Independent life in the elderly (The Nun Study) (Co investigator)

MK-0966 for the Treatment of Mild Cognitive Impairment and Prevention of Conversion of Alzheimer's Disease. (Subinvestigator)

Establishment of Community Based Multispecialty Clinics of Diagnosis and Management of Dementia. A pilot Study. (Subinvestigator)

Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.

(Buciuc M, Whitwell JL, Kasanuki K, Graff-Radford J, Machulda MM, Duffy JR, Strand EA, Lowe VJ, Graff-Radford NR, Rush BK, Franczak MB, Flanagan ME, Baker MC, Rademakers R, Ross OA, Ghetti BF, Parisi JE, Raghunathan A, Reichard RR, Bigio EH, Dickson DW, Josephs KA.) Ann Neurol. 2021 03;89(3):520-533 PMID: 33274526 PMCID: PMC8040336 12/05/2020
Correction: Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction.

(El Hassouni B, Franczak M, Capula M, Vonk CM, Gomez VM, Smolenski RT, Granchi C, Peters GJ, Minutolo F, Giovannetti E.) Oncoscience. 2021;8:46 PMID: 33884286 PMCID: PMC8051325 04/23/2021
Memory Performance and Quantitative Neuroimaging Software in Mild Cognitive Impairment: A Concurrent Validity Study.

(Umfleet LG, Butts AM, Janecek JK, Reiter K, Agarwal M, Brett BL, Ryan JJ, Reuss J, Klein A, Correro AN, Franczak M.) J Int Neuropsychol Soc. 2020 11;26(10):954-962 PMID: 32340636 SCOPUS ID: 2-s2.0-85084404896 04/29/2020
Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction.

(El Hassouni B, Franczak M, Capula M, Vonk CM, Gomez VM, Smolenski RT, Granchi C, Peters GJ, Minutolo F, Giovannetti E.) Oncoscience. 2020 Sep;7(9-10):76-80 PMID: 33195739 PMCID: PMC7640902 11/17/2020
PEERS BENEFIT FROM ADVANCED TRAINING.

(Ashcraft L, Bashor K, Franczak M.) Behav Healthc. 2016;36(2):12-3 PMID: 27505974 08/11/2016
A quantitative description of uncertainty with mild cognitive impairment.

(Sjostedt JM, Bull M, Franczak M.) West J Nurs Res. 2014 Nov;36(10):1374-5 PMID: 25288617 10/08/2014
Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers.

(Li W, Antuono PG, Xie C, Chen G, Jones JL, Ward BD, Singh SP, Franczak MB, Goveas JS, Li SJ.) Cortex. 2014 Aug;57:167-76 PMID: 24905971 PMCID: PMC4448757 SCOPUS ID: 2-s2.0-84901807675 06/07/2014
Effects of the coexistence of late-life depression and mild cognitive impairment on white matter microstructure.

(Li W, Muftuler LT, Chen G, Ward BD, Budde MD, Jones JL, Franczak MB, Antuono PG, Li SJ, Goveas JS.) J Neurol Sci. 2014 Mar 15;338(1-2):46-56 PMID: 24387897 PMCID: PMC4428544 SCOPUS ID: 2-s2.0-84896714136 01/07/2014
Late-life depression, mild cognitive impairment and hippocampal functional network architecture.

(Xie C, Li W, Chen G, Ward BD, Franczak MB, Jones JL, Antuono PG, Li SJ, Goveas JS.) Neuroimage Clin. 2013;3:311-20 PMID: 24273715 PMCID: PMC3814948 11/26/2013
Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults.

(Goveas JS, Xie C, Chen G, Li W, Ward BD, Franczak MB, Jones JL, Antuono PG, Li SJ.) PLoS One. 2013;8(2):e55902 PMID: 23424640 PMCID: PMC3570545 SCOPUS ID: 2-s2.0-84873739878 02/21/2013
The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study.

(Xie C, Li W, Chen G, Douglas Ward B, Franczak MB, Jones JL, Antuono PG, Li SJ, Goveas JS.) Behav Brain Res. 2012 Dec 01;235(2):244-50 PMID: 22909988 PMCID: PMC3561929 SCOPUS ID: 2-s2.0-84865572922 08/23/2012
Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatment.

(Li W, Antuono PG, Xie C, Chen G, Jones JL, Ward BD, Franczak MB, Goveas JS, Li SJ.) Neuroimage. 2012 Apr 02;60(2):1083-91 PMID: 22245641 PMCID: PMC3324180 SCOPUS ID: 2-s2.0-84862777777 01/17/2012